» Articles » PMID: 37052291

Long Non‑coding RNA BLACAT2/miR‑378a‑3p/YY1 Feedback Loop Promotes the Proliferation, Migration and Invasion of Uterine Corpus Endometrial Carcinoma

Overview
Journal Oncol Rep
Specialty Oncology
Date 2023 Apr 13
PMID 37052291
Authors
Affiliations
Soon will be listed here.
Abstract

Uterine corpus endometrial carcinoma (UCEC) is a common gynecological malignancy with high rates of mortality and morbidity. The expression of long non‑coding RNA bladder cancer‑associated transcript 2 (BLACAT2) has been previously found to be aberrantly upregulated in UCEC. However, the regulatory consequences of this in UCEC progression remain poorly understood. In the present study, human UCEC cell lines AN3CA and HEC‑1‑A were infected with lentiviruses to overexpress BLACAT2 (Lv‑BLACAT2) or knock down BLACAT2 using short hairpin RNA (Lv‑shBLACAT2). BLACAT2 overexpression was found to promote the G1/S transition of cell cycle progression and UCEC cell proliferation. In addition, BLACAT2 overexpression was observed to facilitate UCEC cell migration and invasion. By contrast, BLACAT2 knockdown resulted in inhibitory effects in UCEC cell physiology. BLACAT2 overexpression also contributed to the activation of the MEK/ERK pathway. Subsequently, BLACAT2 was demonstrated to bind to microRNA (miR)‑378a‑3p according to dual‑luciferase assays, where it appeared to function as a sponge of miR‑378a‑3p in 293T cells. miR‑378a‑3p overexpression was found to suppress UCEC cell proliferation, invasion, and ERK activation. Lentivirus‑mediated knockdown of its target, the transcription factor Yin Yang‑1 (YY1), was observed to reverse the oncogenic effects of BLACAT2 overexpression. Furthermore, YY1 was found to bind to the promoter of BLACAT2, suggesting that YY1 can regulate BLACAT2 expression. To conclude, results from the present study suggest that BLACAT2, miR‑378a‑3p and YY1 can form a feedback loop instead of an unidirectional axis, which can in turn regulate UCEC tumorigenesis through the MEK/ERK pathway. The present study furthered the understanding of UCEC tumorigenesis and may provide novel therapeutic targets for UCEC treatment.

Citing Articles

SLC8A1, a novel prognostic biomarker and immunotherapy target in RSA and UCEC based on scRNA-seq and pan-cancer analysis.

Chu J, Qin X, Chen W, Xu Z, Xu X Heliyon. 2024; 10(17):e36899.

PMID: 39263055 PMC: 11388753. DOI: 10.1016/j.heliyon.2024.e36899.


The Promotive and Inhibitory Role of Long Non-Coding RNAs in Endometrial Cancer Course-A Review.

Jasielski P, Zawlik I, Bogaczyk A, Potocka N, Paszek S, Mazniak M Cancers (Basel). 2024; 16(11).

PMID: 38893244 PMC: 11171405. DOI: 10.3390/cancers16112125.


LINC00958 as new diagnostic and prognostic biomarker of childhood acute lymphoblastic leukaemia of B cells.

Altieri F, Buono L, Lanzilli M, Mirabelli P, Cianflone A, Beneduce G Front Oncol. 2024; 14:1388154.

PMID: 38884090 PMC: 11176504. DOI: 10.3389/fonc.2024.1388154.


A Novel ceRNET Relying on the lncRNA JPX, miR-378a-3p, and Its mRNA Targets in Lung Cancer.

Mosca N, Pezzullo M, De Leo I, Truda A, Marchese G, Russo A Cancers (Basel). 2024; 16(8).

PMID: 38672608 PMC: 11049386. DOI: 10.3390/cancers16081526.

References
1.
Roberts P, Der C . Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007; 26(22):3291-310. DOI: 10.1038/sj.onc.1210422. View

2.
Luo J, Zhou X, Ge X, Liu P, Cao J, Lu X . Upregulation of Ying Yang 1 (YY1) suppresses esophageal squamous cell carcinoma development through heme oxygenase-1. Cancer Sci. 2013; 104(11):1544-51. PMC: 7656543. DOI: 10.1111/cas.12248. View

3.
Berchuck A, Iversen E, Lancaster J, Pittman J, Luo J, Lee P . Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res. 2005; 11(10):3686-96. DOI: 10.1158/1078-0432.CCR-04-2398. View

4.
Ren Y, Zhao C, He Y, Xu H, Min X . Long non-coding RNA bladder cancer-associated transcript 2 contributes to disease progression, chemoresistance and poor survival of patients with colorectal cancer. Oncol Lett. 2019; 18(2):2050-2058. PMC: 6607385. DOI: 10.3892/ol.2019.10487. View

5.
Wang F, Chen Q, Huang G, Guo X, Li N, Li Y . BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway. BMC Cancer. 2018; 18(1):1128. PMC: 6240221. DOI: 10.1186/s12885-018-5027-9. View